Table 3.

Frequency of the different treatment presentations from 2015 to 2020^a

Treatment and dose for the mean number of patients treated monthly	Year												Total mean (2015–2020)
	2015		2016		2017		2018		2019		2020
	N	%	N	%	N	%	N	%	N	%	N	%	N	%
Donezepil 10 mg	605	17%	689	18%	779	20%	819	21%	865	22%	855	22%	922	20%
Memantine 20 mg	661	18%	739	19%	802	20%	791	20%	748	19%	739	19%	896	19%
Rivastigmine Patch 9.5 mg	852	24%	826	21%	790	20%	710	18%	691	17%	705	18%	915	20%
Donezepil 5 mg	71	2%	100	3%	132	3%	180	5%	218	6%	218	6%	184	4%
Rivastigmine Patch 13.3 mg	90	2%	181	5%	196	5%	194	5%	190	5%	182	5%	207	4%
Rivastigmine Patch 4.6 mg	155	4%	159	4%	160	4%	173	4%	173	4%	180	5%	200	4%
Memantine 10 mg	53	1%	69	2%	86	2%	117	3%	165	4%	160	4%	130	3%
Donezepil 10 mg + Memantine 20 mg	128	4%	143	4%	128	3%	125	3%	133	3%	153	4%	162	3%
Memantine 20 mg + Rivastigmine Patch 9.5 mg	227	6%	171	4%	150	4%	132	3%	129	3%	120	3%	185	4%
Galantamine 24 mg	179	5%	168	4%	157	4%	135	3%	119	3%	109	3%	173	4%
Others	572	16%	607	16%	594	15%	544	14%	524	13%	491	13%	666	14%
Total	3593	100%	3852	100%	3974	100%	3920	100%	3955	100%	3912	100%	4640	100%

^aAverage number of monthly treated patients was obtained every year